Section
|
Topic
|
Authors
|
I. Pathogenesis of vascular complications in diabetes
|
1. Pathogenesis of Dyslipidemia and cardiovascular disease in diabetes
|
Shyi-Jang Shin
|
|
2. The link between kidney and cardiovascular disease: the role of dyslipidemia in diabetic patients
|
Chin-Hsiao Tseng
|
|
3. Role of TG in diabetic vascular disease: focus on Asian population
|
Chin-Hsiao Tseng
|
|
4. Dyslipidemia and diabetic nephropathy - a systemic review
|
Hung-Chun Chen
|
|
5. Dyslipidemia and diabetic retinopathy
|
Wen-Chuan Wu
|
|
6. Genetics of dyslipidemia and diabetes
|
Tjin-Shing Jap
|
|
7. Dyslipidemia and endothelial dysfunction
|
Gerald Watts
|
II. Treatment of vascular complications in diabetes
|
1. Effects of statin on patients with diabetes, residual cardiovascular risk after statin treatment, role of HDL-cholesterol or non-HDL cholesterol
|
Yu-Hung Chang and Yau-Jiunn Lee
|
|
2. Systemic review/meta-analysis of statin/fenofibrate primary prevention in diabetic and non-diabetic patients
|
Yu-Hung Chang and Yau-Jiunn Lee
|
|
3. Effectiveness of statin/fibrate treatment in diabetic nephropathy and chronic kidney disease - a systemic review and meta-analysis
|
Hung-Chun Chen
|
|
4. Pharmacogenetics and pharmacokinetics of lipid-lowering agents
|
Wen-Ter Lai and Chih-Sheng Chu
|
|
5. Does combination therapy with statin/fibrate prevent cardiovascular disease in diabetic patients with atherogenic mixed dyslipidemia?
|
Theodosios D. Filippatos
|
|
6. Comparison of clinical effectiveness of recent statin/fibrate therapy in diabetic patients with atherogenic dyslipidemia
|
Gerald Watts
|
|
7. Systemic review/meta-analysis of non-pharmacologic management of diabetes dyslipidemia
|
Lee-Ming Chuang and J-Y Yu
|
III. Guidelines for the treatment of dyslipidemia and vascular disease in diabetes – lessons learned by clinical outcomes
|
1. Should the official guidelines be re-examined and reformulated for diabetes dyslipidemia management and primary prevention?
|
Shyi-Jang Shin
|
|
2. Development of new guidelines for the treatment of diabetic cardiovascular and renal complications
|
All
|
